Literature DB >> 9696045

YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.

M Austen1, C Cerni, J M Lüscher-Firzlaff, B Lüscher.   

Abstract

The proto-oncoprotein c-Myc and the multifunctional transcriptional regulator YY1 have been shown previously to interact directly in a manner that excludes Max from the complex (Shrivastava et al., 1993). As binding to Max is necessary for all known c-Myc activities we have analysed the influence of YY1 on c-Myc function. We demonstrate that YY1 is a potent inhibitor of c-Myc transforming activity. The region in YY1 required for inhibition corresponds to a functional DNA-binding domain and is distinct from the domains necessary for direct binding to c-Myc. Furthermore the transactivation domain of YY1 was not necessary suggesting that gene regulation by YY1, for example through DNA bending or displacement of regulators from DNA, could be the cause for the negative regulation of c-Myc. This model of indirect regulation of c-Myc by YY1 was supported by the finding that although YY1 did not bind to the c-Myc transactivation domain (TAD) in vitro it was able to inhibit transactivation by Gal4-MycTAD fusion proteins in transient transfections. As for the inhibition of transformation, an intact DNA-binding domain of YY1 was necessary and sufficient for this effect. In addition YY1 did not alter c-Myc/Max DNA binding, further supporting an indirect mode of action. Our findings point to a role of YY1 as a negative regulator of cell growth with a possible involvement in tumor suppression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696045     DOI: 10.1038/sj.onc.1201968

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

2.  Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription.

Authors:  Mengna Li; Yukun Liu; Yanmei Wei; Chunchun Wu; Hanbing Meng; Weihong Niu; Yao Zhou; Heran Wang; Qiuyuan Wen; Songqing Fan; Zheng Li; Xiayu Li; Jianda Zhou; Ke Cao; Wei Xiong; Zhaoyang Zeng; Xiaoling Li; Yuanzheng Qiu; Guiyuan Li; Ming Zhou
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

3.  Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by d-limonene.

Authors:  Tithi Parija; Bibhu Ranjan Das
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

Review 4.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

5.  Transcription regulator Yin-yang 1: from silence to cancer.

Authors:  Weidong Zhu; Samuel Y Olson; Hermes Garbán
Journal:  Crit Rev Oncog       Date:  2011

6.  Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.

Authors:  Shengjie Zhang; Tingting Jiang; Lifeng Feng; Jie Sun; Haiqi Lu; Qinchuan Wang; Min Pan; Dongsheng Huang; Xian Wang; Linbo Wang; Hongchuan Jin
Journal:  J Mol Med (Berl)       Date:  2012-03-06       Impact factor: 4.599

7.  Genome-wide analysis of YY2 versus YY1 target genes.

Authors:  Li Chen; Toshi Shioda; Kathryn R Coser; Mary C Lynch; Chuanwei Yang; Emmett V Schmidt
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

8.  Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.

Authors:  Desmond G Powe; Gulfareen Akhtar; Hany Onsy Habashy; Tarek Abdel-Fatah; Emad A Rakha; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2009-12-21       Impact factor: 6.466

9.  YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling.

Authors:  Chengjie Mei; Xiang Jiang; Yang Gu; Xiaoling Wu; Weijie Ma; Xi Chen; Ganggang Wang; Ye Yao; Yingyi Liu; Zhonglin Zhang; Yufeng Yuan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

Authors:  Jörg Vervoorts; Juliane M Lüscher-Firzlaff; Sabine Rottmann; Richard Lilischkis; Gesa Walsemann; Karen Dohmann; Matthias Austen; Bernhard Lüscher
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.